Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis.
- Conditions
- Cerebral PalsyPainChildren
- Interventions
- Device: Analgesia Nociception Index
- Registration Number
- NCT02364856
- Lead Sponsor
- University Hospital, Lille
- Brief Summary
This study evaluates Analgesia Nociception Index (Heart Rate Variability based index) and its variations after painful stimulations in children with cerebral palsy : acute procedural pain (botulinum toxin injections), and recurrent pain (physiotherapy).
- Detailed Description
Cerebral Palsy (CP) is the most common cause of motor handicap in childhood. CP is caused by damage to the developing brain, resulting in limits in movement, posture, or communication ability. CP affects about one newborn on 450. Pain management is one of the major expectations of CP patients (La Foundation Motrice, 2009) but in this population, pain is not recognized and inadequately treated.
Autonomic nervous system (ANS) is the automatic part of our nervous system regulating vital functions like cardiac beats or respiration. It is divided in sympathetic and parasympathetic. Analysis of heart rate variability (HRV) allows isolation of variations due to parasympathetic and their study. Works from the CIC-IT 807 lead to creation of an index called ANI (Analgesia Nociception Index), which is very sensitive to pain. It is validated on adults (Jeanne, 2012). It could be helpful to assess pain in CP, particularly in patients with communication disabilities. It is important to study this new tool in CP children before developing clinical applications.
Main objective of this study is to demonstrate that ANI is relevant in CP children and that it is sensitive to pain like in adults. Population will be 40 CP children (6-18y) receiving rehabilitation therapy in specialized centres. Duration of the study is 2 years. Parent's consent should be obtained. Investigators will record heart rate of children in 3 conditions in their rehabilitation centres: usual position, acute procedural pain (botulinum toxin injections), and recurrent pain (physiotherapy). Parameters will be calculated in CIC-IT 807 lab (heart rate, ANI). Values of ANI and heart rate before and after painful stimulations will be compared. Correlation between ANI and results of usual pain assessment tools (rFLACC scale, visual analog scale) or characteristics of the population will be analyzed.
Lille University Hospital and CIC-IT 807 lab will collaborate with 2 pediatric rehabilitation centers: Centre Marc Sautelet and Zuydcoote Hospital.
Expected result is that ANI is relevant to CP children. Clinical applications are multiple: pain assessment, adaptation of medical equipment.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 17
- Cerebral Palsy
- Rehabilitation care with physiotherapy and/or toxinum botulinum injections
- Absence of identified autonomic nervous system disease
- Parental and children (if applicable) consent obtained
- French National Health System cover
- baseline Respiratory Frequency > 30/min
- beta-blockers or atropinic treatment
- Pacemaker, cardiac rhythm disease
- Diabetes mellitus
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Children with cerebral palsy Analgesia Nociception Index -
- Primary Outcome Measures
Name Time Method Analgesia Nociception Index ANI before and after painful stimulation 300 seconds before and 300 seconds after painful stimulation ANI is calculated from heart rate recordings 300 seconds before and after painful stimulations and compared
- Secondary Outcome Measures
Name Time Method ANI at baseline 300 seconds at rest ANI calculated from Heart rate recordings during 300 seconds in patient's usual position
time for recovering 10 minutes after painful stimulation time for recovering baseline ANI after painful stimulation
pain score measured by Visual Analog Scale immediately after painful stimulation when VAS will be applicable, children will be asked to score their pain with VAS scale; results of pain ratings with VAS will be compared to ANI results
dysautonomic symptoms inclusion results of ANI measures will be compared between two groups according to presence or absence of dysautonomic symptoms
pain score measured by rFLACC scale immediately after painful stimulation rFLACC scale will be scored immediately after painful stimulation; results of pain ratings with rFLACC will be compared to ANI results
Gross Motor Function Classification System inclusion results of ANI measures will be compared to the severity of motor impairment through the Gross Motor Function Classification System
Trial Locations
- Locations (3)
CHRU de Lille, Pôle Enfant, Hôpital Roger Salengro
🇫🇷Lille, France
Centre de Réadaptation Fonctionnelle Marc Sautelet
🇫🇷Villeneuve-d'Ascq, France
Hôpital maritime de Zuydcoote, Service de SSR Enfant
🇫🇷Zuydcoote, France